نتایج جستجو برای: thin prep

تعداد نتایج: 130322  

2017
Antonio Di Biagio Niccolò Riccardi Alessio Signori Renato Maserati Silvia Nozza Andrea Gori Stefano Bonora Marco Borderi Diego Ripamonti Maria Cristina Rossi Giancarlo Orofino Tiziana Quirino Giuseppe Nunnari Benedetto Maurizio Celesia Salvatore Martini Caterina Sagnelli Giovanni Mazzola Pietro Colletti Dario Bartolozzi Teresa Bini Nicoletta Ladisa Filippo Castelnuovo Annalisa Saracino Sergio Lo Caputo

Several studies have demonstrated the efficacy of the oral pre-exposure prophylaxis (PrEP) with tenofovir (with or without emtricitabine) on preventing HIV-negative partners of HIV infected patients to become infected through sexual contacts. PrEP is already available in the United States and now is approved by European Medicine Agency. In this setting we would like to gauge physicians' knowled...

2016
Daniel Gredig Franziska Uggowitzer Benedikt Hassler Patrick Weber Sibylle Nideröst

Pre-exposure prophylaxis (PrEP) is discussed as an additional HIV prevention method targeting men who have sex with men (MSM). So far, PrEP has not been approved in Switzerland and only little is known about the acceptability of PrEP among MSM living in Switzerland. Given the slow uptake of PrEP among MSM in the USA, the objectives of the study were to investigate the acceptability for PrEP and...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015
Sachin Jain Douglas S Krakower Kenneth H Mayer

Although some individuals who present for antiretroviral postexposure prophylaxis (PEP) had a 1-time exposure to human immunodeficiency virus (HIV), others may be recurrently risky. Given that preexposure prophylaxis (PrEP) has been shown to be efficacious, identification of those individuals who present for PEP who might benefit from PrEP is important to decrease HIV acquisition in high-risk i...

Journal: :AIDS patient care and STDs 2015
Judith D Auerbach Suzanne Kinsky Gina Brown Vignetta Charles

Although the Food and Drug Administration (FDA) approved oral Truvada for pre-exposure prophylaxis (PrEP) for women at risk of HIV infection in the US in July 2012, and the Centers for Disease Control and Prevention (CDC) issued guidance for clinicians to provide PrEP to women "at substantial risk of HIV acquisition" in May 2014, there remain no clinical trial data on efficacy among US women, a...

2015
James Wilton Heather Senn Malika Sharma Darrell HS Tan

Despite significant efforts, the rate of new HIV infections worldwide remains unacceptably high, highlighting the need for new HIV prevention strategies. HIV pre-exposure prophylaxis (PrEP) is a new approach that involves the ongoing use of antiretroviral medications by HIV-negative individuals to reduce the risk of HIV infection. The use of daily tenofovir/emtricitabine as oral PrEP was found ...

2013
Sanjana Mitra David Gogolishvili Jason Globerman

 There were fewer studies published on the potential use of nonoccupational PEP (nPEP) among men who have sex with men than those on PrEP.  Although 47% to 64% of men who have sex with men were aware of nPEP, fewer than 5% had used nPEP (1-3).  The proportion of men who have sex with men aware of PrEP ranged from 13% to 64% (2;4-8), but reported use of PrEP was much lower: from 0.4% to 2% (4...

2009
Jeffrey P. Mower

RNA editing alters plant mitochondrial and chloroplast transcripts by converting specific cytidines to uridines, which usually results in a change in the amino acid sequence of the translated protein. Systematic studies have experimentally identified sites of RNA editing in organellar transcriptomes from several species, but these analyses have not kept pace with rate of genome sequencing. The ...

2018
Erika Aaron Cori Blum Dominika Seidman Mary Jo Hoyt Joanne Simone Meg Sullivan Dawn K. Smith

Preexposure prophylaxis (PrEP) is a highly effective HIV prevention method; however, it is underutilized among women who are at risk for acquisition of HIV. Women comprise one in five HIV diagnoses in the United States, and significant racial disparities in new HIV diagnoses persist. The rate of new HIV diagnoses among black and African American women in 2015 was 16 times greater than that of w...

2015
Kimberly A. Koester

Recent findings PrEP demand has reached a tipping point in the USA and is increasing rapidly. Although the primary benefit of PrEP use is biological, to reduce risk of HIV infection, PrEP users often express an alternative set of social and emotional benefits that are provided by PrEP. These collateral benefits of PrEP have salience, affect, and are experienced in the present, which are compell...

2017
David Gisselquist

Introduction: During 2004-15, nine randomized controlled trials (RCT) for HIV prevention tested pre-exposure prophylaxis (PrEP) with oral drugs, vaginal gels, or vaginal rings among more than 17,000 women in Africa. Methods: This study uses information from the nine RCTs to estimate the proportions of HIV from sexual and bloodborne risks, to consider reasons for success or failure with oral PrE...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید